Cat Allergy in Humans Market

Cat Allergy in Humans Market (Treatment: Antihistamines, Corticosteroid Nasal Sprays, Decongestants, Leukotriene Inhibitors, and Others; Application; Allergy Treatment and Allergy Prevention) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Cat Allergy in Humans Market Outlook 2031

  • The global cat allergy in humans market was valued at US$ 4.2 Bn in 2021
  • The global market is projected to grow at a CAGR of 6.3% from 2022 to 2031
  • The global cat allergy in humans market is anticipated to exceed US$ 7.8 Bn by 2031

Analysts’ Viewpoint on Cat Allergy in Humans Market Scenario

Rising popularity of cats as pets is triggering pet allergic responses in their owners. For instance, cat allergy is highly common in the U.S. and Europe; skin prick tests reveal that 17% of the U.S. population and 8% of the EU population are allergic to cats. Moreover, some families seem to be more susceptible to allergy reactions than others. Therefore, children born into these families are more likely to have allergic diseases. Atopic dermatitis is thought to be linked to this hereditary tendency to develop such diseases. The diagnosis and treatment of patients with allergies pose a challenge. It has been assumed that continuous exposure to cat allergens leads to allergic sensitization and progression to clinically relevant allergic symptoms. Allergy to dogs and cats has long been considered a major risk factor in the development of allergic rhinitis and asthma.

cat allergy in humans market

Overview of Cat Allergy in Humans Market

When people are exposed to various pets, such as dogs and cats, they develop a variety of allergies. The most common types of allergies are runny nose, sneezing, nasal congestion, itchy eyes, as well as skin rash. Allergies to cat is a human allergic reaction to allergens produced by cats. Cat allergens of the most common types are Fel d1 (secreted by the cat's sebaceous glands) and Fel d4 (found in the cat's saliva). pet allergy affects nearly 25% of allergic patients due to Fel d1 and Fel d4 proteins. Cat allergens, particularly Fel d1, are abundant in the form of dander and are thought to be a major cause of allergic asthma around the world. The primary treatment for allergic patients is to avoid cats. Certain allergy Treatment and allergy shots, on the other hand, can help control the symptoms of cat allergies.

Request a sample to get extensive insights into the Cat Allergy in Humans Market

Rise in Adoption of Cats as Pets to Drive Global Market

Pet humanization is becoming a globally accepted term in the pet industry, as an increasing number of pet owners want to provide their pets with human-like products or experiences. For instance, according to Pet data, in 2018, the adoption rate for dogs in China was 11.8% and 19.9% for cats. Increase in R&D for drugs and vaccines for treatment or prevention of pet allergy is expected to drive the demand across the globe.

According to data from Allergy, Asthma & Immunology Research, in 2018, allergies to dogs and cats affected 10% to 20% of the global population with allergic rhino conjunctivitis and allergic asthma. Rising prevalence of various types of pet allergies, increasing investment by manufacturers in the development of novel Cat allergy therapeutics, and growing importance of self-medication are primary factors driving the market.

Allergy-causing Genetic Traits to Contribute to Prevalence Rate of Allergy

An article published by Allergy U.K. stated that children born into families with a history of allergies are more likely to develop allergies as compared to other children. Increase in tendency of families and children to develop allergies due to their genetic links is known as ‘being atopic’. Researchers have estimated that half of the children from atopic families are likely to have allergies themselves. However, this rate in children from non-atopic families is 1 in 5 children who may go on to have an allergy.

Along with lifestyle changes, changing climate with increased pollution, CO2 levels, and particulate matter (PM) across the world are pushing the prevalence and intensity of allergies. In 2020, according to the World Allergy Organization (WAO), allergic rhinitis was one of the most prevalent allergies, affecting 400 million people globally.

Preference for Antihistamine Medication Due to Immediate Relief and Easy Availability

In terms of treatment, the antihistamines segment is projected to dominate the market and account for 50% share by 2031. Antihistamines are the first line of treatment in case of pet allergies. They are cost-effective, easily available, and provide immediate relief. Antihistamines treat allergy symptoms such as nasal congestion, runny nose, sneezing, or itching, nasal passage enlargement, hives, and other skin rashes, and itchy, runny eyes. Treating these symptoms can help the patient feel better during the day and sleep better at night. The antihistamine dosage is determined by the allergy symptoms.

Increase in Prevalence of Allergic Rhinitis to Lead Global Cat Allergy in Humans Market

Based on application, the allergy treatment segment accounted for a major share of 95% of the global market in 2021. Easy availability and low cost of anti-allergy drugs are expected to drive the segment during the forecast period. The growth of the segment is due to rise in prevalence of allergic rhinitis and the expansion of government-funded healthcare programmes to raise awareness about cat litter allergy in humans. Increasing pollution levels around the world as well as distinct genetic changes are driving the allergy treatment segment. Moreover, increase in adoption of immunotherapy to treat pet allergy conditions, owing to good efficacy of therapy is expected to propel the segment over the next few years.

Regional Outlook of Global Cat Allergy in Humans Market

North America dominated the global cat allergy in humans market in 2021. The market in the region is anticipated to grow at a CAGR of 6.1% from 2022 to 2031. The growth of the market in North America can be attributed to high prevalence of cat allergy in humans and increase in pet cat population.

According to the American Academy of Allergy, Asthma, and Immunology, Pet allergies (cat) affect about 15% of the U.S. population each year. In 2014, it was also reported that approximately 14% of children aged 6 to 19 were allergic to cats.

The market in Asia Pacific is estimated to grow at a notable CAGR rate during the forecast period, due to development of appropriate healthcare infrastructure and rise in awareness about progressive immunotherapy, such as allergen immunotherapy, in allergy treatment. Increase in awareness about pet Allergy is also fueling the market in Asia Pacific.

Analysis of Key Players in Global Cat Allergy in Humans Market

The cat allergy in humans market report concludes with the company profiles section, which includes information about key players in the global cat allergy in humans market. Leading players analyzed in the report include Bayer AG, Covis Pharma B.V, HollisterStier Allergy (Jubilant Pharma, Cipla Limited, GlaxoSmithKline plc, Merck & Co., Inc, Regeneron Pharmaceuticals, Inc, Saiba Animal Health AG, Sanofi, and Stallergenes Greer.

Each of these players has been profiled in the cat allergy in humans market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments.

Request a custom report on Cat Allergy in Humans Market

Key Developments in Global Cat Allergy in Humans Market

  • In March 2022, Perrigo Company plc, a leading provider of high-quality, low-cost self-care products, received FDA approval for the over-the-counter use of Nasonex 24HR pet Allergy Relief (mometasone furoate monohydrate 50mcg). This approval is the company's first branded Rx-to-OTC switch, paving the path for Nasonex to enter the OTC market. According to Perrigo, Nasonex 24HR Allergy is expected to be available later this year.
  • In October 2021, the U.S. Food and Drug Administration (USFDA) approved Dupixent, which is used to treat moderate-to-severe asthma for patients aged six to eleven years. Dupixent (dupilumab) helps reduce asthma and pet allergy symptoms in individuals with cat allergies. The approval is expected to enable the company to expand its product portfolio.
  • In June 2021, Bayer AG received FDA approval in the U.S. to transition the in-licensed medicine Astepro Allergy from prescription to over-the-counter status. Astepro pet Allergy is the first and only steroid-free antihistamine nasal spray sold over-the-counter in the U.S. The approval is estimated to help the company to expand its product line as well as its consumer base.

Global Cat Allergy in Humans Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 4.1 Bn

Market Forecast Value in 2031

US$ 7.8 Bn

Growth Rate

CAGR of 6.3 % from Year-to-Year

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Mn for Value

Market Analysis

It includes segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Treatment
    • Antihistamines
    • Corticosteroid Nasal Sprays
    • Decongestants
    • Leukotriene Inhibitors
    • Others
  • Application
    • Allergy Treatment
    • Allergy Prevention
  • Distribution Channel
    • Hospital Pharmacies
    • Retail pharmacies
    • Online Pharmacies

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand

Companies Profiled

  • Bayer AG
  • Covis Pharma B.V
  • HollisterStier Allergy (Jubilant Pharma, Cipla Limited
  • GlaxoSmithKline plc
  • Merck & Co. Inc
  • Regeneron Pharmaceuticals, Inc
  • Saiba Animal Health AG
  • Sanofi, Stallergenes Greer.
  • Other prominent players

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global cat allergy in humans market in 2021?

The global cat allergy in humans market was valued over US$ 4.2 Bn in 2021

How big will be the cat allergy in humans market in 2031?

The global cat allergy market is projected to surpass US$ 7.8 Bn by 2031

What would be the CAGR of global cat allergy in humans market during the forecast period (2022-2031)?

The global cat allergy in humans market is anticipated to record a CAGR of 6.3% from 2022 to 2031

What are the prominent trends impacting the market growth?

Increase in adoption of cats as pets and rise in prevalence of pet allergy have a positive impact on the global market

What was the market share of leading segment of the global cat allergy in humans market?

The antihistamines treatment segment held over 50% share of the global cat allergy in humans market in 2021

Which region is likely to hold a major market share during the forecast period?

North America is expected to account for a major share of the global market during the forecast period

Who are the prominent players in cat allergy in humans market?

Prominent players in the global cat allergy in humans market include Bayer AG, Covis Pharma B.V, HollisterStier Allergy (Jubilant Pharma, Cipla Limited, GlaxoSmithKline plc, Merck & Co., Inc, Regeneron Pharmaceuticals, Inc, Saiba Animal Health AG, Sanofi, and Stallergenes Greer

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Cat Allergy in Humans Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Cat Allergy in Humans Market Analysis and Forecasts, 2017–2031

    5. Key Insights

        5.1. Key Mergers & Acquisitions

        5.2. Allergy Prevalence Data

        5.3. Pipeline Analysis

        5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

    6. Global Cat Allergy in Humans Market Analysis and Forecasts, By Treatment

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast By Treatment, 2017–2031

                6.3.1.1. Antihistamines

            6.3.2. Corticosteroid Nasal Sprays

            6.3.3. Decongestants

            6.3.4. Leukotriene Inhibitors

            6.3.5. Others

        6.4. Market Attractiveness By Treatment

    7. Global Cat Allergy in Humans Market Analysis and Forecasts, By Application

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast By Application, 2017–2031

            7.3.1. Allergy Treatment

            7.3.2. Allergy Prevention

        7.4. Market Attractiveness By Application

    8. Global Cat Allergy in Humans Market Analysis and Forecasts, By Distribution Channel

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast By Distribution Channel, 2017–2031

            8.3.1. Hospital pharmacies

            8.3.2. Retail pharmacies

            8.3.3. Online Pharmacies

        8.4. Market Attractiveness By Distribution Channel

    9. Global Cat Allergy in Humans Market Analysis and Forecasts, By Region

        9.1. Key Findings

        9.2. Market Value Forecast By Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness By Country/Region

    10. North America Cat Allergy in Humans Market  Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast By Treatment, 2017–2031

            10.2.1. Antihistamines

            10.2.2. Corticosteroid Nasal Sprays

            10.2.3. Decongestants

            10.2.4. Leukotriene Inhibitors

            10.2.5. Others

        10.3. Market Value Forecast By Application, 2017–2031

            10.3.1. Allergy Treatment

            10.3.2. Allergy Prevention

        10.4. Market Value Forecast By Distribution Channel, 2017–2031

            10.4.1. Hospital pharmacies

            10.4.2. Retail pharmacies

            10.4.3. Online Pharmacies

        10.5. Market Value Forecast By Country, 2017–2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Treatment

            10.6.2. By Application

            10.6.3. By Distribution Channel

            10.6.4. By Country

    11. Europe Cat Allergy in Humans Market  Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast By Treatment, 2017–2031

            11.2.1. Antihistamines

            11.2.2. Corticosteroid Nasal Sprays

            11.2.3. Decongestants

            11.2.4. Leukotriene Inhibitors

            11.2.5. Others

        11.3. Market Value Forecast By Application, 2017–2031

            11.3.1. Allergy Treatment

            11.3.2. Allergy Prevention

        11.4. Market Value Forecast By Distribution Channel, 2017–2031

            11.4.1. Hospital pharmacies

            11.4.2. Retail pharmacies

            11.4.3. Online Pharmacies

        11.5. Market Value Forecast By Country, 2017–2031

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Italy

            11.5.5. Spain

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Treatment

            11.6.2. By Application

            11.6.3. By Distribution Channel

            11.6.4. By Country

    12. Asia Pacific Cat Allergy in Humans Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast By Treatment, 2017–2031

            12.2.1. Antihistamines

            12.2.2. Corticosteroid Nasal Sprays

            12.2.3. Decongestants

            12.2.4. Leukotriene Inhibitors

            12.2.5. Others

        12.3. Market Value Forecast By Application, 2017–2031

            12.3.1. Allergy Treatment

            12.3.2. Allergy Prevention

        12.4. Market Value Forecast By Distribution Channel, 2017–2031

            12.4.1. Hospital pharmacies

            12.4.2. Retail pharmacies

            12.4.3. Online Pharmacies

        12.5. Market Value Forecast By Country, 2017–2031

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Treatment

            12.6.2. By Application

            12.6.3. By Distribution Channel

            12.6.4. By Country

    13. Latin America Cat Allergy in Humans Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast By Treatment, 2017–2031

            13.2.1. Antihistamines

            13.2.2. Corticosteroid Nasal Sprays

            13.2.3. Decongestants

            13.2.4. Leukotriene Inhibitors

            13.2.5. Others

        13.3. Market Value Forecast By Application, 2017–2031

            13.3.1. Allergy Treatment

            13.3.2. Allergy Prevention

        13.4. Market Value Forecast By Distribution Channel, 2017–2031

            13.4.1. Hospital pharmacies

            13.4.2. Retail pharmacies

            13.4.3. Online Pharmacies

        13.5. Market Value Forecast By Country, 2017–2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Treatment

            13.6.2. By Application

            13.6.3. By Distribution Channel

            13.6.4. By Country

    14. Middle East & Africa Cat Allergy in Humans Market  Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast By Treatment, 2017–2031

            14.2.1. Antihistamines

            14.2.2. Corticosteroid Nasal Sprays

            14.2.3. Decongestants

            14.2.4. Leukotriene Inhibitors

            14.2.5. Others

        14.3. Market Value Forecast By Application, 2017–2031

            14.3.1. Allergy Treatment

            14.3.2. Allergy Prevention

        14.4. Market Value Forecast By Distribution Channel, 2017–2031

            14.4.1. Hospital pharmacies

            14.4.2. Retail pharmacies

            14.4.3. Online Pharmacies

        14.5. Market Value Forecast By Country, 2017–2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Treatment

            14.6.2. By Application

            14.6.3. By Distribution Channel

            14.6.4. By Country

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by tier and size of companies)

        15.2. Market Share Analysis, by Company, 2020

        15.3. Company Profiles

            15.3.1. Bayer AG

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Product Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Strategic Overview

            15.3.2. Covis Pharma B.V

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Product Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Strategic Overview

            15.3.3. HollisterStier Allergy.

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Product Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Strategic Overview

            15.3.4. GlaxoSmithKline plc

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Product Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Strategic Overview

            15.3.5. Merck & Co. Inc.

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Product Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Strategic Overview

            15.3.6. Regeneron Pharmaceuticals, Inc.

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Product Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Strategic Overview

            15.3.7. Saiba Animal Health AG

                15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.7.2. Product Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Strategic Overview

            15.3.8. Sanofi, Stallergenes Greer

                15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.8.2. Product Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Strategic Overview

    List of Tables

    Table 01: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031

    Table 02: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031

    Table 03: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 04: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

    Table 05: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 06: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 07: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031

    Table 08: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031

    Table 09: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 10: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

    Table 11: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

    Table 12: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031

    Table 13: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031

    Table 14: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 15: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

    Table 16: Asia Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 17: Asia-Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031

    Table 18: Asia-Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031

    Table 19: Asia-Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 20: Asia-Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

    Table 21: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 22: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031

    Table 23: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031

    Table 24: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 25: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

    Table 26: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 27: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031

    Table 28: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031

    Table 29: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 30: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

    List of Figures

    Figure 01: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Cat Allergy in Humans Market Value Share, by Treatment, 2020

    Figure 03: Cat Allergy in Humans Market Value Share, by Application, 2020

    Figure 04: Cat Allergy in Humans Market Value Share, by Distribution Channel, 2020

    Figure 05: Global Cat Allergy in Humans Market Value Share Analysis, by Treatment, 2020 and 2031

    Figure 06: Global Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 07: Global Cat Allergy in Humans Market Value (US$ Mn), by Antihistamines, 2017‒2031

    Figure 08: Global Cat Allergy in Humans Market Value (US$ Mn), by Corticosteroid Nasal Sprays, 2017‒2031

    Figure 09: Global Cat Allergy in Humans Market Value (US$ Mn), by Decongestants, 2017‒2031

    Figure 10: Global Cat Allergy in Humans Market Value (US$ Mn), by Leukotriene Inhibitors, 2017‒2031

    Figure 11: Global Cat Allergy in Humans Market Value (US$ Mn), by Others, 2017‒2031

    Figure 12: Global Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031

    Figure 13: Global Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021–2031

    Figure 14: Global Cat Allergy in Humans Market Revenue (US$ Mn), by Allergy Treatment, 2017–2031

    Figure 15: Global Cat Allergy in Humans Market Revenue (US$ Mn), by Allergy Prevention, 2017–2031

    Figure 16: Global Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031

    Figure 17: Global Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021–2031

    Figure 18: Global Cat Allergy in Humans Market Revenue (US$ Mn), by Hospital Pharmacies, 2017–2031

    Figure 19: Global Cat Allergy in Humans Market Revenue (US$ Mn), by Retail Pharmacies, 2017–2031

    Figure 20: Global Cat Allergy in Humans Market Revenue (US$ Mn), by Online Pharmacies, 2017–2031

    Figure 21: Global Cat Allergy in Humans Market Value Share Analysis, by Region, 2020 and 2031

    Figure 22: Global Cat Allergy in Humans Market Attractiveness Analysis, by Region, 2021–2031

    Figure 23: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017–2031

    Figure 24: North America Cat Allergy in Humans Market Value Share Analysis, by Country, 2020 and 2031

    Figure 25: North America Cat Allergy in Humans Market Attractiveness Analysis, by Country, 2021–2031 

    Figure 26: North America Cat Allergy in Humans Market Value Share Analysis, by Treatment, 2020 and 2031

    Figure 27: North America Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 28: North America Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031

    Figure 29: North America Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021–2031

    Figure 30: North America Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031

    Figure 31: North America Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021–2031

    Figure 32: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017–2031

    Figure 33: Europe Cat Allergy in Humans Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 34: Europe Cat Allergy in Humans Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 35: Europe Cat Allergy in Humans Market Value Share Analysis, by Treatment, 2020 and 2031

    Figure 36: Europe Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 37: Europe Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031

    Figure 38: Europe Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021–2031

    Figure 39: Europe Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031

    Figure 40: Europe Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021–2031

    Figure 41: Asia Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017–2031

    Figure 42: Asia Pacific Cat Allergy in Humans Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 43: Asia Pacific Cat Allergy in Humans Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 44: Asia-Pacific Cat Allergy in Humans Market Value Share Analysis, by Treatment, 2020 and 2031

    Figure 45: Asia-Pacific Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 46: Asia-Pacific Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031

    Figure 47: Asia-Pacific Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021–2031

    Figure 48: Asia-Pacific Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031

    Figure 49: Asia-Pacific Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021–2031

    Figure 50: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017–2031

    Figure 51: Latin America Cat Allergy in Humans Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

    Figure 52: Latin America Cat Allergy in Humans Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031

    Figure 53: Latin America Cat Allergy in Humans Market Value Share Analysis, by Treatment , 2020 and 2031

    Figure 54: Latin America Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 55: Latin America Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031

    Figure 56: Latin America Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021–2031

    Figure 57: Latin America Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031

    Figure 58: Latin America Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021–2031

    Figure 59: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017–2031

    Figure 60: Middle East & Africa Cat Allergy in Humans Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

    Figure 61: Middle East & Africa Cat Allergy in Humans Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031

    Figure 62: Middle East & Africa Cat Allergy in Humans Market Value Share Analysis, by Treatment , 2020 and 2031

    Figure 63: Middle East & Africa Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021–2031

    Figure 64: Middle East & Africa Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031

    Figure 65: Middle East & Africa Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021–2031

    Figure 66: Middle East & Africa Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031

    Figure 67: Middle East & Africa Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021–2031

Copyright © Transparency Market Research, Inc. All Rights reserved